Physician profile
Samina Yousuf
NPI 1275582389
$1,882.75
in general payments reported to CMS, 2019-2025
20 companies · $34.93 in 2025
The $34.93 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $322 · 2021: $341 · 2022: $299 · 2023: $341 · 2024: $65.94 · 2025: $34.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $468.82 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $336.36 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $273.04 | 2019-2023 | Mounjaro, Trulicity |
| Exact Sciences Corporation | $143.63 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $87.93 | 2019-2022 | |
| Glaxosmithkline, LLC. | $76.14 | 2019-2021 | |
| Abbvie INC. | $70.10 | 2020-2022 | |
| Astellas Pharma US INC | $65.38 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.46 | 2019-2022 | |
| Pfizer INC. | $55.13 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.27 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $39.21 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.73 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $24.77 | 2019 | |
| Grifols USA, LLC | $24.38 | 2023 | Prolastin-C Liquid |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.78 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.39 | 2021 | |
| Currax Pharmaceuticals LLC | $15.14 | 2021 | |
| Amarin Pharma, INC. | $13.48 | 2021 | |
| Allergan, INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samina Yousuf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.